Detailed information for compound 1629182

Basic information

Technical information
  • TDR Targets ID: 1629182
  • Name: 3-[(3,4-difluorophenyl)methylideneamino]-1-(4 -methoxyphenyl)thiourea
  • MW: 321.345 | Formula: C15H13F2N3OS
  • H donors: 2 H acceptors: 0 LogP: 3.33 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)NC(=S)N/N=C/c1ccc(c(c1)F)F
  • InChi: 1S/C15H13F2N3OS/c1-21-12-5-3-11(4-6-12)19-15(22)20-18-9-10-2-7-13(16)14(17)8-10/h2-9H,1H3,(H2,19,20,22)/b18-9+
  • InChiKey: HMOCRVWDLZAAHF-GIJQJNRQSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 3-[(3,4-difluorophenyl)methyleneamino]-1-(4-methoxyphenyl)thiourea
  • 3-[(3,4-difluorobenzylidene)amino]-1-(4-methoxyphenyl)thiourea
  • T0509-1749
  • MLS001004242
  • SMR000347808

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Mus musculus RAR-related orphan receptor gamma Starlite/ChEMBL No references
Influenza A virus Nonstructural protein 1 Starlite/ChEMBL No references
Homo sapiens geminin, DNA replication inhibitor Starlite/ChEMBL No references
Homo sapiens GNAS complex locus Starlite/ChEMBL No references
Homo sapiens isocitrate dehydrogenase 1 (NADP+), soluble Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Theileria parva isocitrate dehydrogenase (NADP+), putative Get druggable targets OG5_127057 All targets in OG5_127057
Schistosoma japonicum ko:K00031 isocitrate dehydrogenase [EC1.1.1.42], putative Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans N terminus of cytosolic NADP-specific isocitrate dehydrogenase. Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus granulosus guanine nucleotide binding protein Gs subunit Get druggable targets OG5_131088 All targets in OG5_131088
Trypanosoma cruzi isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus granulosus NADP dependent isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium vivax isocitrate dehydrogenase [NADP], mitochondrial, putative Get druggable targets OG5_127057 All targets in OG5_127057
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Trypanosoma brucei gambiense isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium berghei isocitrate dehydrogenase [NADP], mitochondrial, putative Get druggable targets OG5_127057 All targets in OG5_127057
Leishmania donovani isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Toxoplasma gondii isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium yoelii isocitrate dehydrogenase, NADP-dependent, putative Get druggable targets OG5_127057 All targets in OG5_127057
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain Get druggable targets OG5_131088 All targets in OG5_131088
Brugia malayi Isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit Get druggable targets OG5_131088 All targets in OG5_131088
Plasmodium yoelii isocitrate dehydrogenase, NADP-dependent Get druggable targets OG5_127057 All targets in OG5_127057
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative Get druggable targets OG5_131088 All targets in OG5_131088
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium knowlesi isocitrate dehydrogenase [NADP], mitochondrial, putative Get druggable targets OG5_127057 All targets in OG5_127057
Trypanosoma brucei isocitrate dehydrogenase, putative Get druggable targets OG5_127057 All targets in OG5_127057
Leishmania mexicana isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Leishmania infantum isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Schistosoma mansoni NADP-specific isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Trypanosoma congolense isocitrate dehydrogenase, putative Get druggable targets OG5_127057 All targets in OG5_127057
Babesia bovis isocitrate dehydrogenase, NADP-dependent family protein Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium falciparum isocitrate dehydrogenase [NADP], mitochondrial Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans C terminus of cytosolic NADP-specific isocitrate dehydrogenase. Get druggable targets OG5_127057 All targets in OG5_127057
Leishmania major isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Schistosoma japonicum ko:K04632 guanine nucleotide binding protein (G protein), alpha stimulating, putative Get druggable targets OG5_131088 All targets in OG5_131088
Trypanosoma brucei isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Loa Loa (eye worm) isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans cytosolic NADP-specific isocitrate dehydrogenase. Get druggable targets OG5_127057 All targets in OG5_127057
Trypanosoma brucei gambiense isocitrate dehydrogenase, putative Get druggable targets OG5_127057 All targets in OG5_127057
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Trypanosoma cruzi isocitrate dehydrogenase, putative Get druggable targets OG5_127057 All targets in OG5_127057
Neospora caninum Isocitrate dehydrogenase-like protein, related Get druggable targets OG5_127057 All targets in OG5_127057
Toxoplasma gondii isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Leishmania braziliensis isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Candida albicans Mitochondrial NADP-specific isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Neospora caninum hypothetical protein Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus multilocularis isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus granulosus guanine nucleotide binding protein Gs subunit Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Trypanosoma congolense isocitrate dehydrogenase, putative Get druggable targets OG5_127057 All targets in OG5_127057
Brugia malayi isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans Mitochondrial NADP-specific isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus multilocularis isocitrate dehydrogenase 2 (NADP+) Get druggable targets OG5_127057 All targets in OG5_127057

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Mycobacterium tuberculosis Hypothetical protein Nonstructural protein 1   230 aa 202 aa 23.8 %
Schistosoma mansoni GTP-binding protein alpha subunit gna GNAS complex locus 394 aa 450 aa 28.7 %
Brugia malayi Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X geminin, DNA replication inhibitor 209 aa 176 aa 27.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.167 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0998 0.5402 0.5402
Trypanosoma brucei phosphatidylinositol 3-related kinase, putative 0.056 0.2407 0.1803
Trichomonas vaginalis PIKK family atypical protein kinase 0.1242 0.7073 0.7073
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0316 0.0737 0.0503
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7663 0.7663
Trichomonas vaginalis PIKK family atypical protein kinase 0.1242 0.7073 0.7073
Trypanosoma cruzi phosphatidylinositol kinase related protein, putative 0.0316 0.0737 0.0737
Trichomonas vaginalis PIKK family atypical protein kinase 0.167 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.056 0.2407 0.2407
Trichomonas vaginalis PIKK family atypical protein kinase 0.0902 0.4745 0.4745
Trichomonas vaginalis PIKK family atypical protein kinase 0.0998 0.5402 0.5402
Loa Loa (eye worm) hypothetical protein 0.0352 0.0984 0.0984
Trypanosoma cruzi phosphatidylinositol 3-kinase, putative 0.0316 0.0737 0.0737
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.167 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0998 0.5402 0.5402
Trichomonas vaginalis PIKK family atypical protein kinase 0.0316 0.0737 0.0737
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7663 0.7663
Trichomonas vaginalis PIKK family atypical protein kinase 0.0902 0.4745 0.4745
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0316 0.0737 0.0503
Trichomonas vaginalis PIKK family atypical protein kinase 0.1242 0.7073 0.7073
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.167 1 1
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.167 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.1084 0.5992 0.5992
Trichomonas vaginalis PIKK family atypical protein kinase 0.1242 0.7073 0.7073
Trichomonas vaginalis PIKK family atypical protein kinase 0.09 0.4735 0.4735
Toxoplasma gondii target of rapamycin (TOR), putative 0.1242 0.7073 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0902 0.4745 0.4745
Trichomonas vaginalis conserved hypothetical protein 0.0244 0.0247 0.0247
Trichomonas vaginalis PIKK family atypical protein kinase 0.0448 0.1641 0.1641
Trichomonas vaginalis PIKK family atypical protein kinase 0.112 0.6239 0.6239
Schistosoma mansoni fkbp-rapamycin associated protein 0.0316 0.0737 0.0503
Trichomonas vaginalis PIKK family atypical protein kinase 0.0988 0.5335 0.5335
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.056 0.2407 0.2407
Trichomonas vaginalis PIKK family atypical protein kinase 0.09 0.4735 0.4735
Trichomonas vaginalis PIKK family atypical protein kinase 0.0988 0.5335 0.5335
Trypanosoma cruzi target of rapamycin kinase 3 0.133 0.7672 0.7672
Trichomonas vaginalis PIKK family atypical protein kinase 0.056 0.2407 0.2407
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.167 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0316 0.0737 0.0737
Echinococcus granulosus phosphatidylinositol 3 and 4 kinase 0.056 0.2407 0.2215
Echinococcus multilocularis phosphatidylinositol 3 and 4 kinase 0.056 0.2407 0.2215
Loa Loa (eye worm) phosphatidylinositol 3 0.167 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.1242 0.7073 0.7073
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.167 1 1
Loa Loa (eye worm) hypothetical protein 0.0244 0.0247 0.0247
Trypanosoma brucei phosphatidylinositol 3-kinase tor, putative 0.079 0.3979 0.35
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.056 0.2407 0.2407
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.056 0.2407 0.2215
Loa Loa (eye worm) phosphatidylinositol 3 0.056 0.2407 0.2407
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.167 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.167 1 1
Echinococcus granulosus serine protein kinase ATM 0.0316 0.0737 0.0503
Trichomonas vaginalis conserved hypothetical protein 0.0352 0.0984 0.0984
Trichomonas vaginalis PIKK family atypical protein kinase 0.056 0.2407 0.2407
Trichomonas vaginalis PIKK family atypical protein kinase 0.1242 0.7073 0.7073
Echinococcus multilocularis serine protein kinase ATM 0.0316 0.0737 0.0503
Loa Loa (eye worm) hypothetical protein 0.0316 0.0737 0.0737
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7663 0.7663
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7663 0.7663
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.056 0.2407 0.1803
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0694 0.3321 0.279
Echinococcus granulosus serine:threonine protein kinase SMG1 0.0316 0.0737 0.0503
Echinococcus multilocularis serine:threonine protein kinase SMG1 0.0316 0.0737 0.0503
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.167 1 1
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.167 1 1
Toxoplasma gondii non-specific serine/threonine protein kinase 0.0352 0.0984 0.039
Trichomonas vaginalis PIKK family atypical protein kinase 0.056 0.2407 0.2407
Loa Loa (eye worm) hypothetical protein 0.034 0.0904 0.0904
Trichomonas vaginalis PIKK family atypical protein kinase 0.0902 0.4745 0.4745
Trypanosoma brucei target of rapamycin kinase 3, putative 0.133 0.7672 0.7487
Schistosoma mansoni phosphatidylinositol 3-and 4-kinase 0.056 0.2407 0.2215
Trichomonas vaginalis PIKK family atypical protein kinase 0.1242 0.7073 0.7073
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.167 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.056 0.2407 0.2407
Schistosoma mansoni ataxia telangiectasia mutated (atm) 0.0316 0.0737 0.0503
Trichomonas vaginalis PIKK family atypical protein kinase 0.09 0.4735 0.4735
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7663 0.7663
Trichomonas vaginalis PIKK family atypical protein kinase 0.0316 0.0737 0.0737
Trichomonas vaginalis PIKK family atypical protein kinase 0.167 1 1
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.133 0.7672 0.6934
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.167 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.1426 0.833 0.833
Giardia lamblia GTOR 0.167 1 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) = 3.1623 um PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 3.9811 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 5.0119 um PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 7.9433 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 9.2 uM PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 16.3601 uM PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 18.3564 uM PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 25.1189 uM PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 28.1838 uM PUBCHEM_BIOASSAY: qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485366, AID485386, AID504448, AID504454, AID504459] ChEMBL. No reference
Potency (binding) = 35.4813 um PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] ChEMBL. No reference
Potency (functional) 35.4813 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 37.933 uM PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] ChEMBL. No reference
Potency (functional) 89.1251 uM PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.